Introduction
T helper cells have been subdivided into two major subsets, production in T h cells. The majority of studies conducted so far have addressed this issue by analyzing the proximal designated T h 1 and T h 2 cells, according to the lymphokine pattern they secrete. T h 1 cells secrete IL-2, lymphotoxin segments of the IL-2 and IL-4 promoters that are required for the optimal expression of these lymphokines in tumor and IFN-γ, whereas T h 2 cells produce IL-4, IL-5, IL-6, IL-10 and IL-13 (1) . Recent studies have suggested that both cell lines and, in a few cases, in T h 2-like cells (6-11). No extensive studies have been performed to analyze why T subsets differentiate from a common precursor cell, termed T h p, that predominantly expresses IL-2, but not IFN-γ (2, 3) . cells belonging to the subsets of T h 1 and T h 2 cells coordinately express one whole T h -specific set of lympho-IL-12 and IL-4 respectively have been shown to drive the development of T h p cells into either the T h 1 or the T h 2 kines. In the present study, we approach this question using T cell hybridomas made by fusion of BW 5147 subset (4,5). Despite our knowledge on the development of these cells, there is little information on the putative thymoma cells (secreting lymphokines of T h p type) with T cells from four different, well-defined long-term cultured T h 2 molecular mechanisms leading to the selective lymphokine cell clones. We show that the thymoma cells dominantly were hybridized (25) with the following [α- 32 P]dCTP-labeled DNA probes: murine IL-2: 40-377 (PstI-HindIII fragment), suppress the production of the T h 2-type lymphokines IL-4, IL-5 and IL-6 upon fusion with T h 2 cells. At the same time, murine IL-4: 1-356 (BamHI-PstI fragment). Murine β-actin was detected using a PCR-amplified fragment of 574 bp the expression of a T h p-type lymphokine pattern becomes manifest in these T cell hybridomas.
length (26) . The Northern blots were scanned using the Epson GT 8000 and ScanPack software (both from Biometra, Gö ttingen, Germany).
Methods
For reverse transcription, cDNAs were synthesized at 42°C for 90 min in 20 µl reaction mixtures (27) 
Cell lines and fusion
RNA, 50 mM Tris-HCl, pH 8.3, 5 mM MgCl 2 , 1 mM of each The characterization of the four T h 2 cell clones, L1/1 (from a dNTP, 2.5 mM oligo(dT), 32 U RNAguard and 17 U AMV BALB/c mouse; specific for a Leishmania major antigen), reverse transcriptase (all from Pharmacia). For PCR, cDNA D10G4.1 (AKR/J mouse; specific for conalbumin), LNC-4 was amplified in a 40 µl reaction volume containing 50 mM (BALB/c mouse; specific for tuberculin) and BEL-16 (BALB/c Tris-HCl, pH 8.3, 2.5 mM MgCl 2 , 10 mM of each dNTP, 1 U mouse; specific for a L. major antigen), and their in vitro Taq DNA polymerase (Pharmacia) and 100 nM primers during propagation have been described (12-15). All T cells were 35 cycles (1 min denaturation 94°C, 1 min annealing 58°C, 1 cultured in Clicks-RPMI medium (16). T cells to be fused had min extension 72°C). Samples were analyzed on a 1.5 % been re-stimulated with syngeneic spleen cells and antigen agarose gel, followed by scanning on the Epson GT 8000. at least 2 weeks earlier. Before fusion, a Ficoll (Pharmacia, Primers used were as follows: β-actin sense primer 5Ј-CACCCFreiburg, Germany) density gradient was run to remove GCCACCAGTTCGCCA-3Ј, β-actin antisense primer 5Ј-CAGresidual cell debris. Fusion to BW 5147 thymoma cells (17) GTCCCGGCCAGCCAGGT-3Ј (amplified fragment 574 bp); and to rat C58 thymoma cells (18) was performed as published IL-4 sense primer 5Ј-TCTCAACCCCCAGCTAGTTGTCAT-3Ј, (17); however, using a fusion medium consisting of 50% IL-4 antisense primer 5Ј-CCAGGCATCGAAAAGCCCG-3Ј (w/v) PEG 4000, 10% (v/v) DMSO and 40% medium. Success-(amplified fragment 320 bp); IL-2 sense primer 5Ј-AACAGCGful fusion was verified by immunofluorescence testing for cell CACCCACTTCAA-3Ј, IL-2 antisense primer 5Ј-TTGAGATGATsurface markers of parental and hybridoma cells: Thy-1.1 GCTTTGACA-3Ј (amplified fragment 441 bp) (28) . All primers expressed by BW 5147 cells, but not by L1/1, LNC-4 or BELwere located exon-spanning and no PCR products were 16 T h 2 cells; CD3 and CD4 expressed by all T h 2 cells, but obtained with genomic DNA under the PCR conditions used. none of the thymoma cells; Ox 18 expressed by C58 thymoma
Cell transfections and chloramphenicol-acetyl-transferase cells, but none of the T h 2 cells. After fusion, all growing (CAT) assays cells that responded to anti-CD3 stimulation simultaneously expressed the markers of both parental cell lines and therefore Cells were washed twice and resuspended (5ϫ10 6 ) in 235 µl were considered to be hybridomas.
CG-medium (Vitromex, Vilshofen, Germany). Then, 25 µg of DNA per sample in 40 µl water was added and electroporated In vitro stimulation and lymphokine assays using the gene pulser (BioRad, Mü nchen, Germany) set at For the analysis of lymphokine secretion, T h 2 cells and T cell 960 mF capacitance and 280 V. The following CAT constructs hybridomas were stimulated at a density of 2ϫ10 4 /well with were used: pmIL-4 270 CAT 5/2ϩ, pmIL-4 307 CAT 5/2ϩ, either ionomycin (500 ng/ml) and phorbol myristate acetate pmIL-4 797 CAT 5/2ϩ and pmIL-4 6300 CAT 5/2ϩ containing (PMA; 50 ng/ml; both from Sigma, Deisenhofen, Germany) or the base pairs -270 to -12, -307 to -12, -797 to -12 or immobilized anti-CD3 antibodies (19), coated on plastic wells -6300 to -12 of the murine IL-4 promoter; pBL CAT 5/3xPub A (2 µg/ml) (20) . All cultures were performed in 96-well culture IL-4 containing three copies of the Pub A element of the IL-4 plates (Nunc, Roskilde, Denmark) in a final volume of 200 µl.
promoter and pIL CAT 2/1ϩ containing the base pairs -293 Supernatants were removed after culture for 24 h and tested to -7 of the murine IL-2 promoter (11,29). After transfection, for the presence of lymphokines. For screening, IL-2 and ILcells were allowed to rest (5ϫ10 6 /5 ml of culture medium) for 4 were tested by bioassay on HT-2 cells (21), as described 24 h, and then were stimulated for a further 18 h by adding (22). For confirmation, IL-2 and IL-4, as well as IL-5 and IFNionomycin and PMA. Then, the cells were harvested, washed, γ were measured in commercial ELISAs (PharMingen, San lyzed and used in CAT assays (11, 29) . Autoradiographies Diego, CA). IL-6 was measured by bioassay using 7TD1 cells were scanned using the Epson GT 8000 and ScanPack (23) , confirmed by blocking anti-IL-6 antibodies [hybridoma software. 6B4 (24)], as described (22). The detection limits of these assays are provided in Table 1 . For analysis of lymphokine Results mRNA, T cells were stimulated in 24-well microtiter plates (Nunc; total volume: 1.2 ml; 1ϫ10 6 cells/well) using either A total of 302 T cell hybridomas was generated by fusion of immobilized anti-CD3 or PMA plus ionomycin.
four different murine T h 2 cell clones to the murine thymoma cell line BW 5147. The hybridomas were stimulated via RNA analysis their TCR complex using anti-CD3 and screened for their lymphokine secretion by testing the supernatant on HT-2 cells, Total RNA was isolated using the RNeasy Total RNA kit (Quiagen, Hilden, Germany), fractionated on 1.0% agarose the growth of which is stimulated both by IL-2 and IL-4. A total of 74 of the original 302 hybridomas secreted HT-2-gels (20 µg/lane) and blotted onto GeneScreen Plus nylon membranes (NEN, Dreieich, Germany). The Northern blots growth-promoting activity. The remaining 228 hybridomas 
All T cell hybridomas were stimulated (2ϫ10 4 cells/well) with immobilized anti-CD3 antibodies (2 µg/ml). The 24 h supernatants were harvested and tested for the indicated lymphokines, as described in Methods.
a The smallest numbers refer to the detection limits of the respective assay.
b Total number of hybridomas tested.
were non-reactive to anti-CD3-stimulation (as also found by Table 2 . Lymphokine production by a hybridoma derived from murine T h 2/rat thymoma cells microscopic examination, unpublished results). Post-fusion events, e.g. lack of CD3 expression, may explain this nonreactivity. For hybridomas scoring positive, the HT-2 growth-
promoting activity was identified in ELISAs specific for IL-2 or IL-4. The results of the ELISAs (Table 1) They did secrete trace amounts of IL-2 (50 pg/ml), but still 24 h, supernatants were removed and tested for murine IL-2 and no IL-4, after stimulation with the phorbol ester PMA and the murine IL-4 by ELISA. To control for the species specificity of the ELISA, supernatant derived from rat spleen cells activated by concanavalin A Ca 2ϩ ionophore ionomycin.
(2.5 µg/ml) were also tested. Recombinant rat IL-4 also scored negative Similar to IL-4, the synthesis of the T h 2-type lymphokines (Ͻ10 pg/ml) in the IL-4 ELISA.
IL-5 and IL-6 was distinctly suppressed in the hybridomas. Only three out of 74 hybridomas secreted trace amounts of IL-5 Ͻ150 pg/ml (Table 1) . In control experiments, all parental T h 2 cells secreted between 1 and 6 ng/ml of IL-5. Similarly, T h 2 clone. This finding indicates that the phenotype-switch described above for the BW 5147-derived hybridomas is no only two out of 58 hybridomas tested secreted measurable IL-6 bioactivity (0.5 and 700 U/ml respectively), whereas trivial fusion-mediated event, but rather is due to a suppressive mechanism specific for the murine BW 5147 thymoma cells. parental L1/1 T h 2 cells produced Ͼ900 U/ml IL-6. Cell fusion did not create a T h 1-like phenotype, because none of the In the following experiments, we tested whether suppression of T h 2-type lymphokine secretion was due to lack of mRNA. hybridomas expressed measurable amounts of IFN-γ. In summary, these results demonstrate that, after fusion, the To this end, mRNA of the two hybridomas B10.2 and NR12 originating from fusions of BW 5147 cells with the T h 2 clones phenotype of the T h 2 cells changed to a precursor T h p phenotype secreting IL-2, but no IL-4, IL-5, IL-6 and IFN-γ.
L1/1 and LNC-4 respectively was analyzed in Northern blot assays after stimulation of the cells with anti-CD3. As shown In order to investigate whether such changes in T h phenotype are possibly created by the fusion of T h 2 cells to any in Fig. 1 for one out of two experiments with equal results, the RNA from the two anti-CD3-activated hybridomas reacted tumor cell, we fused one of the T h 2 cell clones to a different fusion partner, the rat thymoma cell line C58. Nine hybridomas strongly with an IL-2 probe, but not an IL-4 probe. As expected, mRNA of the parental T h 2 cells reacted with the were generated and two of them produced HT-2 growthpromoting activity. The supernatant of these hybridomas IL-4, but not the IL-2 probe. In all cells, lymphokine mRNA was only detectable upon stimulation. Neither IL-2 mRNA nor contained both murine IL-2 and IL-4, as tested by a speciesspecific ELISA (exemplified by data for hybridoma CL-8-20
IL-4 mRNA was found in the parental BW 5147 cells upon stimulation with anti-CD3 (unpublished results). The in Table 2 ). Therefore, fusion to a rat thymoma cell did not suppress the production of IL-4 by the parental murine hybridoma cells yielded identical results when stimulated for cells, while no such signal was found in control D10G4.1 T h 2 cells which showed an expectedly strong signal for IL-4 mRNA. In addition, a strong IL-4 mRNA signal, but no IL-2 mRNA signal, was detected in parental L1/1 T h 2 cells in two different experiments (not shown). Parental BW 5147 cells (stimulated with PMA and ionomycin) displayed a strong signal for IL-2, but no signal for IL-4, confirming the above reported data on their lymphokine secretion in response to these stimuli. Importantly, however, with this very sensitive technique IL-4 mRNA could clearly be identified (Fig. 2 T h 2 cells to be able to refer to already existing transfection data (9) for this T h 2 cell clone. We used plasmids containing various segments of the IL-4 promoter linked to a CAT reporter gene. As a control, plasmids containing the murine IL-2 promoter/enhancer were transfected in parallel. The PMA/ ionomycin-induced promoter activities were then analyzed in CAT assays. Results of one out of two CAT experiments with similar results are given in Fig. 3 . They show that CAT reporter genes under the control of the IL-4 promoter segments up to a length of 6.3 kb were transcribed in the stimulated hybridoma cells to the same extent as a CAT reporter gene under the control of the IL-2 promoter. In contrast to the results obtained for the hybridoma cells, in T h 2 cells only the IL-4 promoter, but not the IL-2 promoter, was active, as reported (9). These data indicate that if DNA sequences are responsible for a putative suppression of IL-4 gene transcription, they are localized outside of the proximal part of the IL-4 promoter. In addition, the data show that the hybridoma cells habor the relevant intracellular signalling pathways and transcription factors necessary for the activation of the IL-4-promoter. T h 2 clones established from different mice and specific for different antigens. Only one hybridoma secreted normal The RNA preparations obtained from B10.2 hybridoma cells were also analyzed using the RT-PCR technique for the amounts of IL-6, while trace amounts of either IL-5 or IL-6 were secreted by three other hybridomas. The reason for presence of IL-2 or IL-4 mRNA (Fig. 2) . As anticipated, a strong signal for IL-2 mRNA was detected in B10.2 hybridoma normal IL-6 secretion in one single hybridoma is unclear, but A BW 5147-like suppressive mechanism may explain why T h p cells secrete a lymphokine pattern (2) similar to BW 5147 cells in vivo. However, the fact that T h p cells are CD4 ϩ CD8 -, while BW 5147 cells are CD4 -CD8 -(data not shown), suggests that the state of differentiation of these cells is not totally comparable. Possibly, BW 5147 cells represent a cell type less mature than T h p cells and contain a transcriptional machinery which normally is present only after differentiation of naive T h cells into T h p cells.
The suppressive control mechanism for T h 2 lymphokine secretion appears to operate at the level of mRNA, because we were unable to detect IL-4 mRNA in activated hybridoma cells by Northern blotting. However, IL-4 mRNA was detected with the very sensitive RT-PCR technology. This finding indicates that, unlike in T h 1 cells, IL-4 transcription was not shut off in the hybridoma cells. In agreement with this result, we have occasionally detected trace amounts of IL-4 in the supernatant of one hybridoma (B10.2) that was extensively studied throughout this analysis and was mostly negative for IL-4 protein.
Two mechanisms are conceivable for the suppression of IL-4 secretion at the level of mRNA.
IL-4 mRNA could be synthesized at normal levels, but could be altered by post-transcriptional modifications. It has been shown that such modifications may alter the half-life of mRNA for a lymphokine considerably (33) : the half-life of IL-2 mRNA hybridoma cells. This suggests that the mechanism which modified the amount of cytokine mRNA in the cited study (33) may not be accessible in our hybridoma cells. Recently, another type of post-transcriptional modification has been may reside in a mutation of the IL-6 promoter in that individual hybridoma.
reported: the level of mature mRNA for a lymphokine can be reduced by influencing splicing pathways which lead to From the uniformity of the results, we conclude that the suppression of T h 2 lymphokine synthesis is due to a dominant accumulation of more immature RNA species (34,35). However, during our studies we have not obtained any evidence suppressive control mechanism that coordinately affects T h 2-type lymphokines. The mechanism was introduced into the for a significant accumulation of precursor IL-4 RNA in our hybridomas. Also, the uniform suppression of secretion of hybridomas by the parental BW 5147 thymoma cells which secreted small amounts of IL-2, but not IL-4, upon stimulation three different T h 2 lymphokines seems to suggest that posttranscriptional modifications are not decisive for the phenowith PMA and ionomycin. Thus, according to their lymphokine synthesis, the hybridoma cells may be considered as BW type of the hybridomas. However, experiments are in progress to formally rule out this possibility. 5147 cells expressing TCR. The suppressive control mechanism does not operate in any thymoma cell, because no A second explanation for the lack of IL-4 mRNA may be suppression of transcription of the IL-4 gene. Such supprescomparable suppression of T h 2-type lymphokine secretion was observed after fusion of T h 2 cells with rat thymoma cells. sion could be caused by selective methylation and subsequent inactivation of all T h 2 lymphokine genes in the The mechanism appears to be very potent, because it even dominates a functional transcription machinery for T h 2-type hybridoma cells. However, the finding that the hybridoma cells are in principle able to synthesize IL-4 mRNA (as tested lymphokines, a phenotype previously considered to be irreversibly fixed (30, 31) . A different finding of this study also by RT-PCR) argues against this notion. Alternatively, the reason for reduced T h 2 cytokine production in the hybridoma suggests that, at least in principle, the dormant IL-2 gene of a T h 2 cell can be reactivated: when murine T h 2 cells were cells may reside in DNA-binding factors that bind to control sequences in the promoter of the respective lymphokine fused to rat thymoma cells, the introduced rat genes in the hybridomas clearly helped to reactivate the murine IL-2 gene genes and suppress their transcription. If such factors exist, they do not mediate suppression of transcription through (Table 2 ). In accordance, regained IL-2 synthesis of T h 2 cells has also been demonstrated after treatment with cycloheximproximal IL-4 promoter sequences, because even up to a length of 6.3 kb, the proximal IL-4 promotor region mediated ide (32) . cytokine genes (40) . Such regulator sequences could lead to 11 Chuvpilo, S., Schomberg, Ch., Gerwig, R., Heinfling, A., Reeves, a change in the chromatin structure of the promotor, as In conclusion, we have demonstrated a mechanism that 
